FBR Capital Upgrades BioMed Realty (BMR) to Market Perform; Sleight of Acquisition
Tweet Send to a Friend
FBR Capital upgraded BioMed Realty (NYSE: BMR) from Underperform to Market Perform. PT $19.50
FBR analyst says, "Following 3Q10 earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "Following 3Q10 earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
